JPMorgan American (LON:JAM) Shares Cross Below 50-Day Moving Average - Should You Sell?

Key Points

• Shares slipped below the 50-day moving average: JPMorgan American fell under its 50‑day MA of GBX 1,109.82, trading as low as GBX 1,041 and last at GBX 1,060 on volume of 507,666 shares.
• Technical and valuation context: The 200‑day MA is GBX 1,113.02, market cap is £1.79bn with a PE of 23.99 and a beta of 0.76, while leverage appears elevated (debt‑to‑equity 3.91).
• Investment strategy and track record: The trust is a high‑conviction US equities portfolio run by an experienced team and has outperformed its benchmark net of fees over 3, 5 and 10 years.

Shares of JPMorgan American (LON:JAM - ) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 1,109.82 and traded as low as GBX 1,041. JPMorgan American shares last traded at GBX 1,060, with a volume of 507,666 shares.

JPMorgan American Stock Performance

The company has a 50 day simple moving average of GBX 1,109.82 and a 200 day simple moving average of GBX 1,113.02. The company has a debt-to-equity ratio of 3.91, a quick ratio of 1.45 and a current ratio of 0.37. The company has a market capitalization of £1.79 billion, a PE ratio of 23.99 and a beta of 0.76.

JPMorgan American Company Profile

US equities, hand-picked by experts Our flagship American trust offers a high conviction portfolio of both US value and growth stocks that represent the managers' best ideas, designed to outperform across market cycles. The managers' decades of US stock-picking experience underpin a track record of consistent performance and dividends. Key points: Excellence - outperforming the benchmark, net of fees over 3, 5 and 10 years. Expertise - deep in-house stock research Experience - long-standing and proven investment team.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.